Atlas Trials

A Bridging Study of FB2001 in Healthy Subjects

Clinical trial NCT05197179 · COMPLETED

Trial details

NCT number
NCT05197179
Sponsor
Frontier Biotechnologies Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2021-12-29
Primary completion
2022-04-27
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.